It’s another day of ‘good news is bad news’ at Bill Ackman’s nightmare stock – Business Insider
Heres the good news: Valeant Pharmaceuticals has raised $US1.1 billion dollars in asset sales it will use to pay down debt. Its also taking this opportunity to refinance more of its $US30 billion outstanding debt load. Thats also the bad news. The stock is down over 4%, adding to its 20% slide over the last…
Details